CELL INTELLIGENCE · 肿瘤细胞治疗研究

针对 Wilms 瘤的肿瘤微环境与免疫反应：免疫逃逸机制及其对免疫治疗策略的意义

Tumor Microenvironment and Immune Response Against Wilms Tumor: Evasion Mechanisms and Implications for Immunotherapeutic Approaches.

Nemvaleukin alfa 单药治疗晚期黑色素瘤和肾细胞癌患者：1/2 期非随机 ARTISTRY-1 试验结果

Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial.

Nemvaleukin 展示了药效学机制验证，在晚期黑色素瘤和 RCC 患者中具有单药抗肿瘤活性和可控的安全性。

一项静脉注射 mitazalimab（一种 CD40 激动型单克隆抗体）治疗晚期实体瘤患者的 1 期研究

A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumors.